Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. I. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids.
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D004827:Epilepsy / Q000188:drug therapy*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000494:pharmacology / Q000627:therapeutic use*; D010672:Phenytoin / Q000494:pharmacology / Q000627:therapeutic use*; D010743:Phospholipids / Q000097:blood; D014280:Triglycerides / Q000097:blood
D000927:Anticonvulsants; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D010672:Phenytoin; D002784:Cholesterol; D010634:Phenobarbital